相关实验视频

Updated: Jun 10, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

STAT1作为治疗膀癌的潜在治疗点

Qin Zhang¹, Shi Fu¹, Xiaotao Li²

¹Department of Gynaecology, The Second Affiliated Hospital of Kunming Medical University Kunming 650101, Yunnan, China.

International journal of clinical and experimental pathology

|October 14, 2024

概括

信号转换器和转录1激活器 (STAT1) 的过度表达抑制了膀癌细胞的生长和扩散. 在膀癌治疗中,STAT1可能是有前途的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

信号转换器和转录1激活器 (STAT1) 与瘤进展有关.
在膀癌中STAT1的特定作用需要进一步阐明.

研究的目的:

研究STAT1在膀癌中的作用和潜在机制.
评估STAT1作为治疗点的潜力.

主要方法:

在膀癌组织和细胞系中通过RT-qPCR分析STAT1表达.
使用lentivirus在T24细胞中的STAT1过度表达;评估了扩散,入侵和亡.
通过RNA-Seq确定了下游通路;通过RT-qPCR和西欧斑块确认了JAK-STAT通路和SOCS1/SOCS3表达.

主要成果:

STAT1过度表达抑制了膀癌细胞的扩散和入侵.
在体外,增加的STAT1水平增强了细胞亡,并延迟了瘤形成.
RNA-Seq揭示了JAK-STAT通路的激活,在STAT1-过度表达细胞中增加SOCS1和SOCS3的调节.

结论:

在膀癌中,STAT1表现出瘤抑制功能.
在膀癌治疗中,STAT1是潜在的治疗点.

关键词:

膀癌是一种癌症.在SOCS1中,SOCS1是SOCS1.在 SOCS3 中,SOCS3 是 SOCS3 的代名词.美国国家统计局 (STAT1)病变的发生和发病.

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Mouse Bladder Wall Injection

Mouse Bladder Wall Injection

Published on: July 12, 2011

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...